Clinical assessment of memory impairment
64 results
1 - 64
Pharmacological treatment for memory disorder in multiple sclerosis: Cochrane systematic review- Pharmacotherapy for chronic cognitive impairment in traumatic brain injury: Cochrane systematic review
- Memory rehabilitation for people with multiple sclerosis
- Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment
- Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
- Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly: Cochrane systematic review
- Piracetam for dementia or cognitive impairment: Cochrane systematic review
- Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting
- Computerised cognitive training for preventing dementia in people with mild cognitive impairment
- Lecithin for dementia and cognitive impairment: Cochrane systematic review
- 11C‐PIB‐PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Occupational therapy for cognitive impairment in stroke patients
- 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia
- 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment
- Huperzine A for vascular dementia
- Mini‐Cog for the detection of dementia within a community setting
- Clinical judgement by primary care physicians for the diagnosis of all‐cause dementia or cognitive impairment in symptomatic people
- Exergaming for dementia and mild cognitive impairment
- Hormone replacement therapy for cognitive function in postmenopausal women
- Treatment for inhalant dependence and abuse: Cochrane systematic review
- 18F‐FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Ginseng for cognition: Cochrane systematic review
- Selegiline for Alzheimer's disease: Cochrane systematic review
- Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment
- Ginkgo biloba for cognitive impairment and dementia
- L‐carnitine for cognitive enhancement in people without cognitive impairment
- Galantamine for vascular cognitive impairment
- Montreal Cognitive Assessment for the detection of dementia
- Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people
- Mini‐Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)
- Acupuncture for vascular dementia
- Diagnostic test accuracy of self‐administered cognitive assessment tools for dementia
- 18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
- CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Interventions for childhood apraxia of speech
- Rivastigmine for vascular cognitive impairment
- Electroconvulsive therapy for schizophrenia: Cochrane systematic review
- Aerobic exercise to improve cognitive function in older people without known cognitive impairment: Cochrane systematic review
- Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife
- Deep brain and cortical stimulation for epilepsy
- Addenbrooke’s Cognitive Examination III (ACE‐III) and mini‐ACE for the detection of dementia and mild cognitive impairment
- Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review
- Antibiotic regimens for early‐onset neonatal sepsis
- Metal protein attenuating compounds for the treatment of Alzheimer's dementia: Cochrane systematic review
- Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
- Acetylcholinesterase inhibitors for autistic spectrum disorders
- Acetyl‐l‐carnitine for dementia
- Aspirin and other non‐steroidal anti‐inflammatory drugs for the prevention of dementia
- Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis
- AD‐8 for detection of dementia across a variety of healthcare settings
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
- Music interventions for acquired brain injury